◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 9265

Yamashita Health Care Holdings,Inc. (9265) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Distribution · DATA UPDATED 2026-08-09

Yamashita Health Care Holdings,Inc. (9265) operates in the Medical Distribution industry and is headquartered in Fukuoka City, Japan. Its market capitalization is roughly JPY 9 billion. In the fiscal year ended 2025-05-31, 9265 reported JPY 64.5B in revenue and JPY 616M in net income.

Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan.

Interactive charts & full statements →

9265 Revenue & Earnings History — Annual Income Statement

Income statement2025-05-312024-05-312023-05-312022-05-31
Total RevenueJPY 64.5BJPY 61.6BJPY 58.2BJPY 55.1B
Gross ProfitJPY 8.8BJPY 8.5BJPY 8.0BJPY 7.7B
Operating Income (EBIT)JPY 847MJPY 973MJPY 1.2BJPY 937M
Net IncomeJPY 616MJPY 580MJPY 219MJPY 696M

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

9265 Free Cash Flow History

Cash flow2025-05-312024-05-312023-05-312022-05-31
Dividends Paid(JPY 174M)(JPY 122M)(JPY 209M)(JPY 229M)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

9265 Balance Sheet History

Balance sheet2025-05-312024-05-312023-05-312022-05-31
Total AssetsJPY 27.5BJPY 26.6BJPY 24.6BJPY 24.1B
Total LiabilitiesJPY 18.6BJPY 18.0BJPY 16.6BJPY 16.1B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 9265 viewer.

Other Companies in Medical Distribution

← 9264All “0-9” companies9267 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.